AQST: Aquestive Pharma P/S multiplikatori

Aquestive Pharma (AQST) brendining ramzi va logotipi

Sotuvlar nisbatidagi narx dinamikasi Aquestive Therapeutics (AQST) kompaniyasining polimer plyonkalarni ishlab chiqish va FDA to'siqlarini yengib o'tishdagi inson kapitali salohiyatini baholashga yordam beradi. Inyeksiyalarni eruvchan polosalarga almashtirishning innovatsion usuli bemorlar qulayligini oshiradi, barqaror geosiyosiy fon esa biznes xavfsizligini ta'minlaydi. 10.10 qiymati joriy parametr qiymati vazifasini o'tab, aksiyalar narxi va kompaniyaning haqiqiy tijorat muvaffaqiyati o'rtasidagi fundamental bog'liqlikni tasdiqlaydi.

Aquestive Therapeutics (AQST) Kapitalizatsiyaning daromadga nisbati: 04.07.2022 - 14.11.2026 davri uchun

Aquestive Pharma (AQST) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi aquestive.com|AQST - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor kapitallashuvi Aquestive Pharma|AQST - Kompaniyaning to‘liq qiymati
- balans bo'yicha xususiy kapital ma'lumotlari:
Yagona aksiya balans qiymati Aquestive Therapeutics|AQST - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati aquestive.com|AQST - Kompaniyaning umumiy aktivlari
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Aquestive Therapeutics|AQST - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Aquestive Corp|AQST - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Aquestive Pharma|AQST - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Aquestive Therapeutics|Tezkor likvidlik aquestive.com
- foyda va bozor multiplikatorlari tafsilotlari:
AQST - Sof foyda|Kutilayotgan sof foyda Aquestive Therapeutics|AQST - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Aquestive Therapeutics Inc|AQST - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Aquestive Pharma|AQST - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda Aquestive Therapeutics|AQST - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi aquestive.com|AQST - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Aquestive Therapeutics
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
AQST - Daromad va sotish hajmi|Prognoz qilingan sotish hajmi aquestive.com|AQST - Narxning daromadga nisbati|Kelajakdagi narxning daromadga nisbati Aquestive Pharma
Kompaniyaning jamlanma tahliliyoti:aquestive.com
Aquestive Therapeutics seriyali mahsuloti

Bozor kapitalizatsiyasining yillik savdo aylanmasiga nisbati bir dollarlik daromadning tannarxini o'lchaydi, bu esa tijorat ishga tushirish bosqichidagi kompaniyalarni baholash uchun juda muhimdir. Aquestive Therapeutics (AQST) kompaniyasining narx/savdo ko'paytiruvchisiga tahlil qilish uning innovatsion dori filmlariga bo'lgan bozor kutuvlarini haqiqiy monetizatsiya darajalari bilan bog'lash imkonini beradi va joriy narxning tarixiy kontekst hamda kelgusidagi tartibga soluvchi tasdiqlarga nisbatan adolatli ekanligini aniqlaydi.

Raqobatdosh kompaniyalar

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori KVUE (Kenvue)|P/S multiplikatori Verona Pharma PLC VRNA|MENS - Narxning daromadga nisbati|Narx/daromad multiplikatori Ligand Corp (LGND)|AMRX (Amneal Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|perrigo.com (PRGO) - P/S multiplikatori|ALVO (Alvotech SA) - P/S multiplikatori|Sotuvga nisbatan narx Liquidia Corp LQDA|Narxning daromadga nisbati Galapagos Genomics (GLPG)|Narx/daromad koeffitsiyenti ANI Pharmaceuticals Corp|MannKind Corporation - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati AMPH (amphastar.com)|Pacira BioSciences, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti ARS Pharmaceuticals Inc SPRY|TBPH (Theravance) - Kapitalizatsiyaning daromadga nisbati|SCPH (scPharmaceuticals) - Narxning daromadga nisbati|TECX (Tectonic Therapeutic Inc.) - P/S multiplikatori|Sotuvga nisbatan narx tonixpharma.com TNXP|Kapitalizatsiyaning daromadga nisbati SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Bozor kapitallashuvining daromadga nisbati|BioHarvest - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati EXOZ (Invizyne)|Oramed Pharma - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ENTX (Entera Bio Ltd.)|HYFT: P/S multiplikatori|Sotuvga nisbatan narx ABVC BioPharma Inc. (ABVC)|Narxning daromadga nisbati Cumberland Pharma|QNTM: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori FGEN|P/S multiplikatori telomirpharma.com (TELO)|Narxning daromadga nisbati Rani Therapeutics Holdings, Inc. RANI|SNYR (Synergy CHC Corp.) - Narxning sotuvga nisbati|Rallybio Corp. - P/S multiplikatori|Sotuvga nisbatan narx Lexaria Bioscience|PULM (Pulmatrix, Inc.) - Kapitalizatsiyaning daromadga nisbati|Pheton Holdings (PTHL) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati APM|LYRA (Lyra Therapeutics Inc.) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori IBO|Narx/daromad koeffitsiyenti tnfpharma.com|P/S multiplikatori YCBD (cbdMD)|PRFX - Kapitalizatsiyaning daromadga nisbati|CYTO - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Lipella Pharmaceuticals Inc LIPO|OPTN: P/S multiplikatori|Pieris Pharma (PIRS) - P/S multiplikatori|Narxning daromadga nisbati Procaps Group S.A.|PTPI - Narx/daromad multiplikatori|Narxning daromadga nisbati Qilian International Holding (QLI)|Narx/daromad koeffitsiyenti Acelyrin Inc.|TFF Pharma - Kapitalizatsiyaning daromadga nisbati